Virpax Pharmaceuticals, Inc., a Delaware-incorporated company listed on the Nasdaq Capital Market under the trading symbol VRPX, filed a Form 8-K report with the United States Securities and Exchange Commission on September 16, 2024. The report announced the immediate resignation of Dr. Vanila M. Singh from the company's Board of Directors. Dr. Singh's departure from the board was effective as of the date of the report. The company has not provided any further details regarding the resignation or any plans for a successor.

Virpax Pharmaceuticals, Inc., a Delaware-incorporated company listed on the Nasdaq Capital Market under the trading symbol VRPX, filed a Form 8-K report with the United States Securities and Exchange Commission on September 16, 2024. The report announced the immediate resignation of Dr. Vanila M. Singh from the company's Board of Directors. Dr. Singh's departure from the board was effective as of the date of the report. The company has not provided any further details regarding the resignation or any plans for a successor.